Dear Colleagues,
I have the great pleasure in inviting you to join us at APASL STC on NAFLD/NASH to be held from 6 to 8 October, 2022, in Yerevan, Armenia.
Non-alcoholic fatty liver disease (NAFLD) is a very common disorder and refers to a group of conditions where there is accumulation of excess fat in the liver of people who drink little or no alcohol. THE GLOBAL PREVALENCE OF NAFLD: About one fourth of world’s population have NAFLD, the most common form of NAFLD is a non serious condition called fatty liver. In fatty liver, fat accumulates in the liver cells. Although having fat in the liver is not normal, by itself it probably does not damage the liver. A small group of people with NAFLD may have a more serious condition named non-alcoholic steatohepatitis (NASH). In NASH, fat accumulation is associated with liver cell inflammation and different degrees of scarring. NASH is a potentially serious condition that may lead to severe liver scarring and cirrhosis and HCC.
This three-day meeting will focus on all aspects of the management of NAFLD/NASH and will include important topics of epidemiology, Causes Symptoms, Risk Factors , Screening/Diagnosis as well as optimal current treatment approaches in patients including . Our aim is to invite all experts in the field to present the latest research data and share their experience as well as to create new plan for future. STC will be based on active discussion and interactions in order to get necessary results and new challenges in NAFLD/NASH ( MAFLD?). We are expecting 500 delegates from the whole world including CIS countries to attend this important conference.
I hope you will enjoy this conference as well as your stay in Armenia, the country with old history, culture and amazing hospitality and traditions.
With kindest regards
Hasmik Ghazinyan
MD, PHD Head of Hepatological clinic of NCID (National Centre for Infectious Diseases)
President of Armenian Hepatological Association for the study of the liver